Article Information
History
- March 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rossana Elena Chahla1,
- Luis Medina Ruiz2,
- Teresa Mena3,
- Yolanda Brepe3,
- Paola Terranova3,
- Eugenia Silvana Ortega4,
- Guillermo Gabriel Barrenechea4,
- Daniel Gustavo Goroso5 and
- Maria de los Angeles Peral de Bruno4,*
- 1Head SI.PRO.SA (Province Health System), Ministry of Health, Tucumán, Argentina
- 2President of the Medical Executive Secretary, SI.PRO.SA Tucumán, Argentina
- 3Primary Care service network, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
- 4Health Research Institute, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
- 5Research and Technology Center, Mogi das Cruzes University, Brazil, Human Motor Skill Analysis Laboratory, National University of Tucumán, Tucumán, Argentina
- ↵*Corresponding author:
Maria Peral de Bruno, Ph.D., Health Research Institute, Ministry of Health., Virgen de La Merced 196., (4000) San Miguel de Tucumán, Tucumán, Argentina., E-mail: mperal0150{at}gmail.com, Pronouns: She, her, hers.
Posted March 30, 2021.
IVERMECTIN REPROPOSING FOR COVID-19 TREATMENT OUTPATIENTS IN MILD STAGE IN PRIMARY HEALTH CARE CENTERS
